.

Def Leppard and Journey Tour Rocked Over 1 Million Fans 2018 In Review


01-04-2019
Def Leppard

(hennemusic) Def Leppard and Journey Tour Rocked Over 1 Million Fans was a top 18 story of October 2018: The recently-completed co-headlining tour of North America by rock heavyweights Def Leppard and Journey played to more than 1 million fans on the continent.

Billboard reports the extensive six-month, 58-date series sold 1,003,198 tickets to earn a total box office revenue of $97.1 million. The biggest single-show revenue was the fourth and final leg's opener - a September 21 stop at AT&T Park in San Francisco, CA - which grossed $3.9 million.

The biggest venue on the run's 10-show stadium series was a June 1 gig at Toronto's Rogers Centre, with 45,083 tickets available for sale. Def Leppard and Journey wrapped up the North American run with a two-night engagement at the Forum in Inglewood, CA on October 6-7.

The groups' previous joint tour in 2006 took in gross revenue of $38 million over 72 dates. Read more here.

hennemusic is an official news provider for antiMusic.com.
Copyright hennemusic - Excerpted here with permission.


Related Stories


Def Leppard And ZZ Top Announce Fall Tour Dates

Def Leppard, Motley Crue, Poison Tour Has Sold Over A Million Tickets

Def Leppard Announce Early Years Box Set

Motley Crue, Def Leppard Add Band To Stadium Tour

Def Leppard Filmed Residency For Possible Release 2019 In Review

Def Leppard Frontman Addresses Criticism Over Live Focus

Def Leppard Defer Over Big Screen Biopic 2019 In Review

Def Leppard End 2019 With Fun Look Back

Def Leppard Wanted To Mix AC/DC With Queen 2019 In Review

Def Leppard And Motley Crue Still Working Out Stadium Tour Details

More Def Leppard News

Share this article

Share on Facebook Share on Twitter Share on Google+ Pin it Share on Reddit email this article



advertisement

advertisement


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2020 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.